| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |